Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2785 - 2792 of 12086 results

Discretion Retained: USPTO Dodges Attack from Big Tech to Rein in Discretionary IPR Denials
November 22, 2021| Blog| Viewpoint

Who’s in Charge Here? Federal Circuit Says An Arbitrator, not District Court, Should Decide Arbitrability
November 22, 2021| Blog| Viewpoint

OSHA Vaccine Rule Blocked Permanently by Fifth Circuit, But Judicial Review Will Continue
November 19, 2021| Blog| Viewpoint

About Face: Laboratory-Developed Tests for COVID-19 Now Subject to EUA Requirements
November 19, 2021| Blog| Viewpoint

Mintz Lawyer’s New Book Puts 11 Faces on America’s Immigration ‘Crisis’
November 19, 2021| News

New York Significantly Expands its Whistleblower Law
November 19, 2021| Blog| Viewpoint

Examining Art Units to Avoid Subject Matter Eligibility Challenges for Bioinformatics and AI-related Patents
November 18, 2021| Blog| Viewpoint

Should Employers Keep Preparing for the COVID-19 ETS?
November 16, 2021| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
